167 related articles for article (PubMed ID: 18367108)
21. Molecular inhibition of phospholipase cgamma signaling abrogates DU-145 prostate tumor cell invasion.
Turner T; Epps-Fung MV; Kassis J; Wells A
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2275-82. PubMed ID: 9815625
[TBL] [Abstract][Full Text] [Related]
22. [Overexpression of human tumor metastasis-related gene TMSG-1 suppresses cell proliferation and invasion of a highly metastatic prostate cancer cell line PC-3M-1E8 in vitro].
Su J; You JF; Wang JL; Cui XL; Fang WG; Zheng J
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):404-7. PubMed ID: 19024511
[TBL] [Abstract][Full Text] [Related]
23. Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivo.
Aigner A; Renneberg H; Bojunga J; Apel J; Nelson PS; Czubayko F
Oncogene; 2002 Aug; 21(37):5733-42. PubMed ID: 12173043
[TBL] [Abstract][Full Text] [Related]
24. [Role of Rho GTPase in inhibiting metastatic ability of human prostate cancer cell line PC-3 by omega-3 polyunsaturated fatty acid].
Yi L; Zhang QY; Mi MT
Ai Zheng; 2007 Dec; 26(12):1281-6. PubMed ID: 18076787
[TBL] [Abstract][Full Text] [Related]
25. [Effects of vimentin on invasion and metastasis of prostate cancer cell lines PC-3M-1E8 and PC-3M-2B4].
Wei JC; Wu MF; Zhang YT; Zhao LP; Lu YP; Ma D
Ai Zheng; 2008 Jan; 27(1):30-4. PubMed ID: 18184460
[TBL] [Abstract][Full Text] [Related]
26. COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness.
Scarpino S; Duranti E; Stoppacciaro A; Pilozzi E; Natoli G; Sciacchitano S; Luciani E; Ruco L
J Pathol; 2009 Aug; 218(4):487-94. PubMed ID: 19391129
[TBL] [Abstract][Full Text] [Related]
27. Prosaptide TX14A stimulates growth, migration, and invasion and activates the Raf-MEK-ERK-RSK-Elk-1 signaling pathway in prostate cancer cells.
Koochekpour S; Sartor O; Lee TJ; Zieske A; Patten DY; Hiraiwa M; Sandhoff K; Remmel N; Minokadeh A
Prostate; 2004 Oct; 61(2):114-23. PubMed ID: 15305334
[TBL] [Abstract][Full Text] [Related]
28. [Interferon-gamma decreases the adhesiveness and invasiveness of prostate cancer cells].
Gao L; Yang DJ; Lin XG; Xu WH; Wang XM
Zhonghua Nan Ke Xue; 2008 Jun; 14(6):513-6. PubMed ID: 18649748
[TBL] [Abstract][Full Text] [Related]
29. IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells.
Pitulis N; Papageorgiou E; Tenta R; Lembessis P; Koutsilieris M
Anticancer Res; 2009 Jun; 29(6):2331-7. PubMed ID: 19528499
[TBL] [Abstract][Full Text] [Related]
30. Enhanced hepatocyte growth factor level in human prostate cancer treated with endocrine therapy.
Tsuka H; Mori H; Li B; Kanamaru H; Matsukawa S; Okada K
Int J Oncol; 1998 Jul; 13(1):169-76. PubMed ID: 9625818
[TBL] [Abstract][Full Text] [Related]
31. Bladder cancer cell invasion is enhanced by cross-talk with fibroblasts through hepatocyte growth factor.
Wang P; Nishitani MA; Tanimoto S; Kishimoto T; Fukumori T; Takahashi M; Kanayama HO
Urology; 2007 Apr; 69(4):780-4. PubMed ID: 17445681
[TBL] [Abstract][Full Text] [Related]
32. [Effects of hepatocyte growth factor gene transfection on adriamycin-induced apoptosis of gastric cancer cells in vitro].
Shen JG; Cheong JH; Noh SH; Wang LB
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):338-41. PubMed ID: 17892127
[TBL] [Abstract][Full Text] [Related]
33. GDF-9 promotes the growth of prostate cancer cells by protecting them from apoptosis.
Bokobza SM; Ye L; Kynaston HG; Jiang WG
J Cell Physiol; 2010 Nov; 225(2):529-36. PubMed ID: 20458753
[TBL] [Abstract][Full Text] [Related]
34. ErbB-4 may control behavior of prostate cancer cells and serve as a target for molecular therapy.
Ben-Yosef R; Starr A; Karaush V; Loew V; Lev-Ari S; Barnea I; Lidawi G; Shtabsky A; Greif Y; Yarden Y; Vexler A
Prostate; 2007 Jun; 67(8):871-80. PubMed ID: 17440944
[TBL] [Abstract][Full Text] [Related]
35. (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells.
Lim YC; Park HY; Hwang HS; Kang SU; Pyun JH; Lee MH; Choi EC; Kim CH
Cancer Lett; 2008 Nov; 271(1):140-52. PubMed ID: 18632202
[TBL] [Abstract][Full Text] [Related]
36. Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells.
Davies G; Jiang WG; Mason MD
J Urol; 2000 Mar; 163(3):985-92. PubMed ID: 10688036
[TBL] [Abstract][Full Text] [Related]
37. HGF/SF up-regulates the expression of bone morphogenetic protein 7 in prostate cancer cells.
Ye L; Lewis-Russell JM; Sanders AJ; Kynaston H; Jiang WG
Urol Oncol; 2008; 26(2):190-7. PubMed ID: 18312940
[TBL] [Abstract][Full Text] [Related]
38. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.
Davies G; Mason MD; Martin TA; Parr C; Watkins G; Lane J; Matsumoto K; Nakamura T; Jiang WG
Int J Cancer; 2003 Sep; 106(3):348-54. PubMed ID: 12845672
[TBL] [Abstract][Full Text] [Related]
39. [Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro].
Deng G; Yu JH; Ye ZQ; Hu ZQ
Zhonghua Nan Ke Xue; 2008 Feb; 14(2):116-21. PubMed ID: 18390174
[TBL] [Abstract][Full Text] [Related]
40. Erythromycin and clarithromycin modulation of growth factor-induced expression of heparanase mRNA on human lung cancer cells in vitro.
Sasaki M; Ito T; Kashima M; Fukui S; Izumiyama N; Watanabe A; Sano M; Fujiwara Y; Miura M
Mediators Inflamm; 2001 Oct; 10(5):259-67. PubMed ID: 11759110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
